Clinical trials: Aged Skin

Aged Skin

An Efficacy and Safety Study Evaluating Treatment Sessions of Restylane Skinboosters Vital Lidocaine in the Face

• Completed
• Age: 35 to 45 years
• Phase 4
• Medical device
• Results posted

A randomised, multi-centre, parallel-group efficacy and safety study evaluating two and three initial treatment sessions of Restylane Skinboosters Vital Lidocaine in the face.

Trial name

NCT02403986

Testing

Restylane Vital Skinboosters Lidocaine

Where

Germany

Volunteers

53 people

Sponsor

Galderma R&D